Skip to main content
Top
Published in: Current Obesity Reports 4/2019

Open Access 01-12-2019 | Obesity | Psychological Issues (V Drapeau and V Ivezaj, Section Editors)

Obesity and Eating Disturbance: the Role of TFEQ Restraint and Disinhibition

Authors: Eleanor J. Bryant, Javairia Rehman, Lisa B. Pepper, Elizabeth R. Walters

Published in: Current Obesity Reports | Issue 4/2019

Login to get access

Abstract

Purpose of Review

Literature from the past five years exploring roles of Three-Factor Eating Questionnaire (TFEQ) Restraint and Disinhibition in relation to adult obesity and eating disturbance (ED) was reviewed.

Recent Findings

Restraint has a mixed impact on weight regulation, diet quality, and vulnerability to ED, where it is related detrimentally to weight regulation, diet, and psychopathology, yet can serve as a protective factor. The impact of Disinhibition is potently related to increased obesity, poorer diet, hedonically driven food choices, and a higher susceptibility to ED.

Summary

Restraint and Disinhibition have distinct influences on obesity and ED and should be targeted differently in interventions. Further work is required to elucidate the mechanisms underlying TFEQ eating behavior traits.
Literature
2.
go back to reference Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985;29(1):71–83.CrossRef Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985;29(1):71–83.CrossRef
3.
go back to reference Herman CP, Mack D. Restrained and unrestrained eating. J Pers. 1975;43(4):647–60.CrossRef Herman CP, Mack D. Restrained and unrestrained eating. J Pers. 1975;43(4):647–60.CrossRef
8.
go back to reference Westenhoefer J, Stunkard AJ, Pudel V. Validation of the flexible and rigid control dimensions of dietary restraint. The International journal of eating disorders. 1999;26(1):53–64.CrossRef Westenhoefer J, Stunkard AJ, Pudel V. Validation of the flexible and rigid control dimensions of dietary restraint. The International journal of eating disorders. 1999;26(1):53–64.CrossRef
10.
go back to reference Cappelleri JC, Bushmakin AG, Gerber RA, Leidy NK, Sexton CC, Lowe MR, et al. Psychometric analysis of the Three-Factor Eating Questionnaire-R21: results from a large diverse sample of obese and non-obese participants. Int J of Obesity. (2005). 2009;33(6):611–20. https://doi.org/10.1038/ijo.2009.74.CrossRef Cappelleri JC, Bushmakin AG, Gerber RA, Leidy NK, Sexton CC, Lowe MR, et al. Psychometric analysis of the Three-Factor Eating Questionnaire-R21: results from a large diverse sample of obese and non-obese participants. Int J of Obesity. (2005). 2009;33(6):611–20. https://​doi.​org/​10.​1038/​ijo.​2009.​74.CrossRef
11.
go back to reference Karlsson J, Persson LO, Sjostrom L, Sullivan M. Psychometric properties and factor structure of the Three-Factor Eating Questionnaire (TFEQ) in obese men and women. Results from the Swedish Obese Subjects (SOS) study. Int J of Obesity. 2000;24(12):1715–25.CrossRef Karlsson J, Persson LO, Sjostrom L, Sullivan M. Psychometric properties and factor structure of the Three-Factor Eating Questionnaire (TFEQ) in obese men and women. Results from the Swedish Obese Subjects (SOS) study. Int J of Obesity. 2000;24(12):1715–25.CrossRef
12.
go back to reference Martín-García M, Vila-Maldonado S, Rodríguez-Gómez I, Faya FM, Plaza-Carmona M, Pastor-Vicedo JC, et al. The Spanish version of the Three Factor Eating Questionnaire-R21 for children and adolescents (TFEQ-R21C): Ppychometric analysis and relationships with body composition and fitness variables. Physiol Behav. 2016;165:350–7. https://doi.org/10.1016/j.physbeh.2016.08.015.CrossRefPubMed Martín-García M, Vila-Maldonado S, Rodríguez-Gómez I, Faya FM, Plaza-Carmona M, Pastor-Vicedo JC, et al. The Spanish version of the Three Factor Eating Questionnaire-R21 for children and adolescents (TFEQ-R21C): Ppychometric analysis and relationships with body composition and fitness variables. Physiol Behav. 2016;165:350–7. https://​doi.​org/​10.​1016/​j.​physbeh.​2016.​08.​015.CrossRefPubMed
27.
83.
87.
go back to reference Sanchez M, Darimont C, Panahi S, Drapeau V, Marette A, Taylor VH et al. Effects of a diet-based weight-reducing program with probiotic supplementation on satiety efficiency, eating behaviour traits, and psychosocial behaviours in obese individuals. Nutrients. 2017;9(3). doi:10.3390/nu9030284.CrossRef Sanchez M, Darimont C, Panahi S, Drapeau V, Marette A, Taylor VH et al. Effects of a diet-based weight-reducing program with probiotic supplementation on satiety efficiency, eating behaviour traits, and psychosocial behaviours in obese individuals. Nutrients. 2017;9(3). doi:10.3390/nu9030284.CrossRef
92.
go back to reference Gradaschi R, Noli G, Cornicelli M, Camerini G, Scopinaro N, Adami GF. Do clinical and behavioural correlates of obese patients seeking bariatric surgery differ from those of individuals involved in conservative weight loss programme? J Hum Nutr Diet. 2013;26(Suppl 1):34–8. https://doi.org/10.1111/jhn.12080.CrossRefPubMed Gradaschi R, Noli G, Cornicelli M, Camerini G, Scopinaro N, Adami GF. Do clinical and behavioural correlates of obese patients seeking bariatric surgery differ from those of individuals involved in conservative weight loss programme? J Hum Nutr Diet. 2013;26(Suppl 1):34–8. https://​doi.​org/​10.​1111/​jhn.​12080.CrossRefPubMed
94.
go back to reference Konttinen H, Peltonen M, Sjostrom L, Carlsson L, Karlsson J. Psychological aspects of eating behavior as predictors of 10-y weight changes after surgical and conventional treatment of severe obesity: results from the Swedish Obese Subjects intervention study. Am J Clin Nutr. 2015;101(1):16–24. https://doi.org/10.3945/ajcn.114.095182.CrossRefPubMed Konttinen H, Peltonen M, Sjostrom L, Carlsson L, Karlsson J. Psychological aspects of eating behavior as predictors of 10-y weight changes after surgical and conventional treatment of severe obesity: results from the Swedish Obese Subjects intervention study. Am J Clin Nutr. 2015;101(1):16–24. https://​doi.​org/​10.​3945/​ajcn.​114.​095182.CrossRefPubMed
101.
go back to reference Alarcon Del Agua I, Socas-Macias M, Busetto L, Torres-Garcia A, Barranco-Moreno A. Garcia de Luna PP et al. Post-implant analysis of epidemiologic and eating behavior data related to weight loss effectiveness in obese patients treated with gastric electrical stimulation. Obes Surg. 2017;27(6):1573–80. https://doi.org/10.1007/s11695-016-2495-3.CrossRefPubMed Alarcon Del Agua I, Socas-Macias M, Busetto L, Torres-Garcia A, Barranco-Moreno A. Garcia de Luna PP et al. Post-implant analysis of epidemiologic and eating behavior data related to weight loss effectiveness in obese patients treated with gastric electrical stimulation. Obes Surg. 2017;27(6):1573–80. https://​doi.​org/​10.​1007/​s11695-016-2495-3.CrossRefPubMed
Metadata
Title
Obesity and Eating Disturbance: the Role of TFEQ Restraint and Disinhibition
Authors
Eleanor J. Bryant
Javairia Rehman
Lisa B. Pepper
Elizabeth R. Walters
Publication date
01-12-2019
Publisher
Springer US
Keywords
Obesity
Obesity
Published in
Current Obesity Reports / Issue 4/2019
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-019-00365-x

Other articles of this Issue 4/2019

Current Obesity Reports 4/2019 Go to the issue

The Obesity Epidemic: Causes and Consequences (A Cameron and K Backholer, Section Editors)

Global Implementation of Obesity Prevention Policies: a Review of Progress, Politics, and the Path Forward

The Obesity Epidemic: Causes and Consequences (A Cameron and K Backholer, Section Editors)

Can Diets Be Healthy, Sustainable, and Equitable?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine